Search Results - "Durant, Jacques"
-
1
COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated
Published in PloS one (05-01-2017)“…COPD is a frequent and significant cause of respiratory morbidity in HIV-infected patients despite the control of HIV. We aimed to analyze the factors…”
Get full text
Journal Article -
2
Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up
Published in Viruses (28-04-2022)“…Objective: Immunadapt is a study evaluating the impact of combination antiretroviral treatment (cART) simplification on immune activation. We previously showed…”
Get full text
Journal Article -
3
Prevalence and Main Clinical Characteristics of Fully Vaccinated Patients Admitted to Hospital for Delta Variant COVID-19
Published in Frontiers in medicine (02-03-2022)“…The Delta variant of the novel beta coronavirus responsible for the current coronavirus pandemic (COVID-19) spread across Europe during the summer of 2021…”
Get full text
Journal Article -
4
Switching to a Dual-Drug Regimen in HIV-Infected Patients Could Be Associated With Macrophage Activation?
Published in Frontiers in medicine (12-08-2021)“…Objectives: The aim of this study was to evaluate the effect on immune activation of switching from a triple-drug to a dual-drug regimen in HIV-1 infected…”
Get full text
Journal Article -
5
Active hepatitis C is associated with a larger HIV reservoir in successfully treated patients
Published in Journal of Virus Eradication (01-05-2018)Get full text
Journal Article -
6
Emergence of Lyme Disease on the French Riviera, a Retrospective Survey
Published in Frontiers in medicine (22-03-2022)“…The French Riviera has been declared free of Lyme Borreliosis (LB) for years. Many patients are referred for presumed LB, sometimes with atypical clinical…”
Get full text
Journal Article -
7
Exercise stereotypes and fatigue in people living with HIV: does self-efficacy play a mediating or a moderating role?
Published in Archives of public health = Archives belges de santé publique (30-04-2018)“…Recent research suggests that exercise stereotypes may influence physical activity through ego depletion and internalization mechanisms. The objective of this…”
Get full text
Journal Article -
8
HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)
Published in Heliyon (01-02-2017)“…HIV-associated neurocognitive disorders (HAND) persist in the post-HAART era, characterized by asymptomatic neurocognitive impairment (ANI) and mild…”
Get full text
Journal Article -
9
Long-Term Treatment with Lopinavir-Ritonavir Induces a Reduction in Peripheral Adipose Depots in Mice
Published in Antimicrobial Agents and Chemotherapy (01-12-2006)“…ERRATUM ( vol. 51 , p. 1587 ) Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg…”
Get full text
Journal Article -
10
Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection
Published in World journal of hepatology (28-08-2015)“…AIM: To evaluate virological response to telaprevir or boceprevir in combination with pegylated interferon and ribavirin and resistance mutations to NS3/4A…”
Get full text
Journal Article -
11
Erratum to ‘HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)’
Published in Heliyon (01-03-2017)“…[This corrects the article DOI: 10.1016/j.heliyon.2017.e00245.]…”
Get full text
Journal Article -
12
Sensitive Enzyme Immunoassay for Measuring Plasma and Intracellular Nevirapine Levels in Human Immunodeficiency Virus-Infected Patients
Published in Antimicrobial Agents and Chemotherapy (01-01-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
13
Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptions
Published in AIDS (London) (13-06-2003)“…To monitor the disappearance of resistance-associated mutations and reappearance of wild-type (WT) virus during structured treatment interruptions (STI) using…”
Get full text
Journal Article -
14
Prevalence of osteoporosis in people living with HIV and risk factors associated in the cART era
Published in HIV medicine (01-10-2023)Get full text
Journal Article -
15
Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study
Published in The Journal of infectious diseases (01-03-2013)“…Background. Dolutegravir (DTG; S/GSK1349572), a human immunodeficiency virus type 1 (HIV-1) integrase inhibitor, has limited cross-resistance to raltegravir…”
Get full text
Journal Article -
16
Determination of ddATP Levels in Human Immunodeficiency Virus-Infected Patients Treated with Dideoxyinosine
Published in Antimicrobial Agents and Chemotherapy (01-02-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
17
Detection of emerging tick-borne disease agents in the Alpes-Maritimes region, southeastern France
Published in Ticks and tick-borne diseases (01-11-2021)“…Lyme borreliosis is a zoonotic tick-borne infection representing the most frequent vector-borne disease in the northern hemisphere. The Mediterranean rim is…”
Get full text
Journal Article -
18
Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
Published in The Journal of infectious diseases (01-08-2014)“…Background. The pilot phase IIb VIKING study suggested that dolutegravir (DTG), a human immunodeficiency virus (HIV) integrase inhibitor (INI), would be…”
Get full text
Journal Article -
19
Unusual Cutaneous Manifestations of Miliary Tuberculosis
Published in Clinical infectious diseases (01-01-2000)“…Cutaneous manifestations of miliary tuberculosis are extremely rare. We describe a 62-year-old woman with leukopenia who developed infiltrated…”
Get full text
Journal Article -
20
Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
Published in AIDS (London) (20-02-2014)“…OBJECTIVE:To assess changes over time in neuropsychological test results (NPr) and risk factors among a regularly followed HIV-infected patient population…”
Get full text
Journal Article